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AbstrACt 
Introduction Traumatic brachial plexus injury (TBPI) 
involves major trauma to the large nerves of the arm 
which control the movement and sensation. Fifty per 
cent of injuries result in complete paralysis of the arm 
with many other individuals having little movement, 
sensation loss and unremitting pain. The injury often 
causes severe and permanent disability affecting work 
and social life, with an estimated cost to the National 
Health Service and the economy of £35 million per annum. 
Advances in microsurgery have resulted in an increase 
in interventions aimed at reconstructing these injuries. 
However, data to guide evidence-based decisions is 
lacking. Different outcomes are used across studies to 
assess the effectiveness of treatments. This has impeded 
our ability to synthesise results to determine which 
treatments work best. Studies frequently report short-term 
clinical outcomes but rarely report longer term outcomes 
and those focused on quality of life. This project aims 
to produce a core outcome set (COS) for surgical and 
conservative management of TBPI. The TBPI COS will 
contain a minimum set of outcomes to be reported and 
measured in effectiveness studies and collected through 
routine clinical care.
Methods and analysis This mixed-methods project 
will be conducted in two phases. In phase 1 a long list of 
patient-reported and clinical outcomes will be identified 
through a systematic review. Interviews will then explore 
outcomes important to patients. In phase 2, the outcomes 
identified across the systematic review, and the interviews 
will be included in a three-round online Delphi exercise 
aiming to reach consensus on the COS. The Delphi 
process will include patient and healthcare participants. A 
consensus meeting will be held to achieve the final COS.
Ethics and dissemination The use of a COS in TBPI will 
increase the relevance of research and clinical care to all 
stakeholders, facilitate evidence synthesis and evidence-
based decision making. The study has ethical approval.
trial registration numbers CRD42018109843.
IntroduCtIon
A traumatic brachial plexus injury (TBPI) is 
an insult to the whole or part of the brachial 
plexus. A TBPI typically occurs in young men 
in their 20s and early 30s,1–4 and the majority 
result from motor vehicle accidents.3–6 Many 
patients have permanent denervation to the 
muscles in the arm, which results in complete 
paralysis, significant life-long pain and 
disability.6–8 TBPI accounts for 1.2% of poly-
trauma.5 9 Although the injury is relatively 
rare, its complex and chronic nature is associ-
ated with a combined National Health Service 
and ongoing economic cost of £35 million 
annually.10 Moreover, the incidence and costs 
are rising with improved survival following 
major trauma11 12 and associated increase in 
injury complexity13 resulting in significant 
societal and economic burden.
Recent advances in nerve microsurgery 
have increased the available reconstructive 
options.14 Studies evaluating outcomes from 
surgery focus on short-term clinician-reported 
outcomes such as early recovery of strength 
and movement.2 15–19 Yet final outcome 
following a TBPI or an associated interven-
tion may not be seen until after 3 years. In 
addition, outcomes prioritised by patients, 
such as pain8 social disability7 20 21 and return 
to work22 23 are rarely measured,19 resulting in 
a mismatch between what outcomes patients 
and clinicians prioritise as important. 
Furthermore, studies of TBPI commonly 
collect and report differing outcomes which 
are often poorly defined, making it impos-
sible to compare or combine results.19
strengths and limitations of this study
 ► A core outcome set will facilitate evidence synthesis 
in traumatic brachial plexus injury.
 ► A systematic review will identify the outcomes re-
ported in recent trials and observational studies.
 ► Patient interviews will ensure that outcomes import-
ant to patients are identified.
 ► The Delphi and consensus meeting will include in-
ternational patient and professional participants.
 ► Future research will be needed to agree a mea-
surement instrument for each outcome in the core 
outcome set
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The Clinical Advisory Group on services within major 
trauma recommend that more research is conducted on 
outcome measurement.24 Specifically, there is international 
agreement that a battery of outcome measures is necessary 
to assess all aspects of the impact of a TBPI on the indi-
vidual.19 25 Moreover, the UK patient group (TBPI Society 
UK) has highlighted the need to focus on outcomes such as 
pain, emotion and psychology.26 Patient and public consul-
tation, in preparation for this project, also revealed that 
patients felt that the broader impact of a TBPI on an indi-
vidual was not addressed by current outcome assessment.
One solution is to develop a core outcome set (COS) 
for surgical and conservative management of TBPI. A COS 
contains a minimum agreed set of outcomes to be reported 
and measured in all studies and collected through routine 
clinical care.27–29 A number of COS in different clinical areas 
have been developed and are supported by Cochrane Collab-
oration reviewers and research funders.30 31 COS method-
ology is being refined and promoted by the Core Outcome 
Measures in Effectiveness Trials (COMET) initiative.32
A core outcome set for TBPI, derived through collab-
oration between patients and clinicians/researchers, will 
ensure that future studies collect outcomes that are mean-
ingful to patients and address all key concerns.33 If outcomes 
are standardised, then interventions can be fully evalu-
ated while minimising outcome-reporting bias.34 Using a 
COS to monitor clinical outcomes will facilitate consistent 
benchmarking of services and identify opportunities to 
raise clinical practice standards. A search of the COMET 
initiative database (http://www. comet- inititative. org/) was 
completed prior to commencing the project. No published 
or ongoing COS for clinical practice or effectiveness trials 
involving patients with traumatic brachial plexus injuries 
were identified.
Aim
The aim of the project is to produce a COS for TBPI rele-
vant to patients, healthcare professionals and academics.
scope
The scope of this COS is intended for international 
routine clinical care and clinical studies evaluating the 
effectiveness of interventions (surgical and conservative) 
for adults with a TBPI.
Health condition
TBPI.
Population
Adults >18 years of age.
types of interventions
All surgical and non-surgical interventions.
MEtHod
The development of this COS adheres to COMET and 
COS-Standards for Development (COS-STAD) recom-
mendations.35 36 The study is a mixed-method design 
involving the use of both qualitative and quantitative 
methodologies. A Delphi study informed by data from 
the systematic review and qualitative interviews, and 
a consensus meeting will be undertaken to achieve 
consensus on the COS.
There will be two phases:
1. Identification of an outcome long list through:
a. Systematic literature review to identify clinical and 
patient-reported outcomes relevant to TBPI care.
b. Semi-structured interviews to identify outcomes im-
portant to patients.
c. Reduction of the long list by grouping similar items 
together into domains and to create questionnaire 
items for the Delphi.
2. Prioritisation of outcomes through an online three-
round Delphi and a consensus meeting to agree the 
final COS.
Phase 1: Identification of an outcome long list
The aim of phase 1 is to identify a comprehensive list of 
outcomes important to patients with TBPI and to clini-
cians and researchers. This will be achieved through a 
systematic review of outcomes reported in the literature 
and interviews with individuals with a TBPI to gain their 
views on what outcome domains should be measured. 
Combining the results of the systematic review and 
patient interviews will generate a long list of outcome 
domains (eg, pain, movement) to be taken forward to the 
Delphi study.
Systematic review
A systematic review of literature evaluating the effec-
tiveness of surgical and non-surgical interventions for 
patients with TBPI will be undertaken to identify clinical 
and patient reported outcomes.
The systematic review will:
1. Identify clinical and patient-reported outcomes report-
ed in studies evaluating treatments in TBPI.
2. Identify measurement tools used to assess outcomes.
With few prospective or randomised trials in this clin-
ical area, the criteria for inclusion will be any controlled 
and uncontrolled experimental or observational studies 
evaluating any intervention in adult TBPI including case 
reports, case series, case studies, prospective and retrospec-
tive cohort studies and randomised and non-randomised 
clinical trials. The definition of an intervention includes 
any surgical or non-surgical care. Clinical outcomes 
and outcome measurement tools are those relevant to 
assessment of patient’s recovery and well-being and will 
include short-term outcomes including adverse events 
and complications of surgical and non-surgical care and 
long-term outcomes, for example, quality of life.
The search will be limited to the last 5 years so that 
outcomes extracted reflect use in recent studies relating 
to modern treatment of TBPI. Non-English language 
publications will be included. Conference abstracts will 
be excluded due to the high risk of duplication with 
published studies. Studies will not be excluded because 
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of research quality due to the exploratory nature of 
the review. For searching, Medical Subject Headings 
including subheadings, publication types and supple-
mentary concepts will be used. Free text (keywords) will 
also be applied to the term (see online supplementary 
appendix A for the MEDLINE(OVID) search strategy).
Titles, then abstracts will be independently screened 
by two reviewers. Disagreements will be resolved through 
discussion with the study management group if neces-
sary. Exclusions, with reasons, will be noted at each stage. 
Clinical and patient-reported outcomes and patient-re-
ported outcome measures (PROMS) will be extracted 
from eligible full texts by one reviewer (CM) using a pilot-
tested data extraction form. A second reviewer will inde-
pendently extract outcome data. Dual data extraction will 
stop when outcomes extracted are identical for the last 10 
studies. Study details to be extracted will include authors, 
date, country, study design, participant demographics 
(mean age, sex, type of TBPI, participant numbers), 
reported outcomes, adverse events or complications, 
outcome definition, outcome measures and time point of 
measures after injury.
Where a PROM has been used, it will be documented 
and the original PROM acquired and data extracted 
as recommended by Macefield et al.37 The following 
data will be extracted, verbatim name for PRO scales as 
termed by PROM developer, verbatim name for single 
items as termed by PROM developer, all PROM items 
(scale components and any single items) and details of 
any additional non-validated questions.
A narrative synthesis will be conducted with results 
presented in tables. Methodological quality of the 
included studies will not be assessed as the aim of the 
review is to identify outcomes reported in intervention 
studies with TBPI participants regardless of study quality. 
A summary of all outcomes used will be generated, 
including frequency analysis and relationship to time and 
geographic area. A summary of the technique/tools used 
to assess each outcome will be made.
Semi-structured interviews
Semi-structured qualitative interviews will be undertaken 
to identify and explore outcomes important to patients 
with a TBPI.
This study will:
a. Identify outcomes important to individuals with a 
TBPI.
b. Facilitate understanding of why these outcomes are 
important.
c. Identify appropriate language for outcome domains to 
be used in the Delphi.
d. Facilitate comparison between outcomes identified in 
the systematic review.
Method
The study design was informed by the Consolidated 
Criteria for Reporting Qualitative Research (COREQ).38 
The approach will be pragmatic, reflecting the need to 
identify all outcomes important to individuals with a 
TBPI.39
Inclusion criteria
Types of participants
 ► Adults >18 years of age.
 ► Patients who have completed or are receiving treat-
ment for TBPI.
 ► Able to participate in an interview in the English 
language.
Types of pathology
 ► TBPI.
Types of intervention
 ► All surgical and non-surgical interventions for TBPI.
Exclusion criteria
Types of participant
 ► Unable to give informed consent.
Types of pathology
 ► Other significant comorbidities that could impact 
cognition or peripheral neurological function, for 
example, a traumatic brain injury.
Sampling
CM will screen the peripheral nerve injury database 
and peripheral nerve clinic lists at the Queen Elizabeth 
Hospital Birmingham, a tertiary regional referral centre 
and specialist unit for patients with TBPI. Potential 
participants on the peripheral nerve injury database will 
be sent an invitation letter and asked to contact CM if 
interested in participating in the study. Potential partici-
pants identified on the clinic lists will be approached by 
a member of the multidisciplinary team (physiotherapist, 
occupational therapist, surgeon, specialist nurse or senior 
registrar). The study will be explained, and they will be 
provided with a patient information leaflet. Patients will 
have as much time as necessary to consider the study and 
take the information leaflet home to discuss with family 
and friends. Patients will be asked to contact CM if they 
are interested in the study. At this time, the study will be 
explained again, and any questions will be answered. If 
the patient is interested in participating, then a conve-
nient time and date for a 1:1 interview will be negoti-
ated. One-to-one interviews will be conducted by a single 
researcher(CM). A ‘maximum variation sample’ will be 
sought40 41 so that outcomes generated from the inter-
views cover the spectrum of dysfunction associated with 
a TBPI. A sampling framework, constructed to reflect 
important characteristics such as age, sex, type of TBPI, 
type of interventions received and time since injury, will 
serve as a guide to recruiting participants for the study. It 
is envisaged that no more than 15–17 participants will be 
required for data saturation.42
Interview location
Interviews will be face to face at a location and time of 
the patient’s choice which could include the partici-
pants home or an interview room at the Queen Elizabeth 
Hospital Birmingham. Participants will be reimbursed 
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for travel expenses for travelling to and from interview 
locations.
Interview format
The discussion will explore how the injury has impacted 
on each participant's life and what their ideal outcomes 
and expectations are for treatments. A topic guide using 
open questions and follow-up prompts, developed and 
piloted with members from the patient advisory group, 
will be used. This will ensure that the most important 
aspects are covered while allowing flexibility to explore 
concepts raised by participants.
Data analysis
Data analysis43 44 will be undertaken concurrently with 
data collection through thematic analysis. The interviews 
will be digitally recorded, and the recordings downloaded 
to a secure computer then removed from the recording 
devise. Anonymised recordings will be securely trans-
ferred to a transcription company. Anonymised tran-
scripts will be reviewed line by line and words and phrases 
and passages related to important outcomes following a 
TBPI or related to treatments will be coded. A second 
reviewer will code 10% of the transcripts to enhance cred-
ibility of the analysis. Differences in codes and emergent 
themes will be discussed. A member of the patient advisory 
group will be supported to read a selection of uncoded 
transcripts and suggest codes or themes. This will assist 
with the interpretation (from a patient’s perspective) 
and which may be different to that of the research team. 
Themes will be discussed and agreed with members of the 
research team (CJH and JC). The lead author (CM) will 
carry out interviews until no new themes emerge. From 
this analysis, we will develop a list of outcomes important 
to patients with TBPI.
Consultation exercise
The aim of this consultation exercise will be to identify, 
from the list of outcomes identified in the systematic 
review and the semi-structured interviews, what outcomes 
should be entered into phase 2 of the study.
Study overview and method
The list of outcomes from the systematic review and the 
interviews with patients will be combined. Each outcome 
from phase one will be categorised independently by two 
authors (DP and CM) into one of 36 domains developed 
by a collaboration between COMET and Cochrane.45 
Outcome domains like these have previously been used 
by other COS developers.46 47 Outcome domains will 
include physiological/clinical, function, global quality of 
life and adverse events. The scope of the outcomes will be 
defined, and a common language and description will be 
identified for each of the outcomes through an iterative 
process between the patient advisors, lead investigator 
and key members of the research team.
CM will present all outcomes within the COMET and 
Cochrane framework45 at a consultation meeting with 
the patient advisor, research team and two clinicians. 
The objective is to ensure clear and appropriate mean-
ings with no duplication. The outcome domains will be 
reviewed to assess the suitability of the domain name and 
grouping of outcomes and descriptors. The ‘long list’ of 
outcomes will be developed into a plain English question-
naire in collaboration with the patient advisory group and 
the research group for use in the Delphi Study.
Phase 2: delphi and consensus meeting
A Delphi method is frequently used to achieve consensus 
for COS.48 49 Time, financial constraints and carbon foot-
print make this the best option for international expert 
and patient involvement. A Delphi allows anonymity and 
gives equal weight to all who participate reducing the 
potential for individuals or group of individuals being 
overly influential in the process.50
Method
We will recruit three panels for the online Delphi.
Patient experience panel
Individuals with TBPI will be recruited through the Trau-
matic Brachial Plexus UK charity website and their social 
media outputs (Twitter and Facebook). A study video will 
be hosted on the website and promoted through social 
media. Potential participants will be asked to contact the 
chief investigator (CM) if interested in participating. This 
may favour individuals who have had a TBPI for many 
years and those accessing online self-help groups, there-
fore, the peripheral nerve database (n=208) at the Queen 
Elizabeth Hospital Birmingham will also be screened. A 
purposive sample from the database will receive an invita-
tion to participate.
Surgical panel
Direct approaches to known experts will be made for 
participation. Researchers will contact the British Asso-
ciation of Orthopaedic Surgeons, British Association of 
Plastic, Reconstructive and Anaesthetic surgeons and 
American Society for Surgery of the Hand to act as gate-
keepers, seeking to identify experts for the Delphi study. 
Invitations to participate will be distributed via their 
websites/newsletter or email. Interested members can 
then therefore register though this link and confirm their 
eligibility.
Non-surgical panel
Similar to surgical panel experts known to researchers will 
be approached directly. Working with The British Associa-
tion of Hand Therapy, Association of Trauma and Ortho-
paedic Physiotherapists and international equivalents, 
the advert for the Delphi will be distributed through their 
websites, mailing lists and newsletters.
Participants (patients and healthcare practitioners) 
will rate the importance of each outcome through a 
three-round online Delphi. Participants will receive an 
email link to the questionnaire embedded in the UK 
traumatic brachial plexus support website. The Delphi 
Manager software developed by the COMET Initiative 
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to manage COS development (http://www. comet- initia-
tive. org/ delphimanager/) will be used. A paper copy 
may also be sent if requested. Within the questionnaire, 
outcomes will be grouped into domains so that similar or 
related outcomes can be viewed together. Questions, with 
outcomes written in lay terms, will have medical terms 
explained on hovering with the mouse. Participants will 
rate the importance of each outcome on a nine-point 
Likert scale as recommended by the Grading of Recom-
mendations Assessment, Development and Evaluation 
working group,51 1=not important and 9=critical for each 
outcome. Participants will have the option to add addi-
tional outcomes in round 1. These will be added to the 
second-round questionnaire if deemed ‘new’ and within 
the scope of the COS. After each round, results will be 
fed back to the participants within subsequent question-
naires. Participants will be able to review:
 ► The score they gave the outcome in the previous 
round.
 ► The mean score given to that outcome by each stake-
holder group including their own.
 ► Anonymised free-text comments for any outcome.
This will allow participants to reflect, review and change 
their scores from the previous rounds. The method of 
feedback is important so will be discussed, piloted and 
refined with the patient and clinical advisory group.
All outcomes from round 1 will remain in round 2 to 
allow participants to reconsider in the light of feedback 
attached. Items from round 2 will continue to the next 
round if any item scores between 7 and 9 (important) 
by 50% or over and between 1 and 3 (not important) by 
less than 15% in any stakeholder group. Outcomes, not 
meeting the criteria, will be discarded. Participants will 
then rescore each outcome retained in round 3.
All outcomes which meet the ‘Consensus IN’ criteria 
(see box 1) in any stakeholder group will be taken 
forward for ratification at the consensus meeting. All 
outcomes which meet the criteria ‘Consensus OUT’ in 
all stakeholder groups will not be taken forward to the 
consensus meeting. Where ‘NO Consensus’ has occurred, 
the results of these outcomes in each stakeholder group 
will be taken forward to the consensus meeting and 
presented for discussion.
Sample size
There is no consensus regarding the optimal sample size 
for a Delphi study; therefore, recruitment will be based 
on previous Delphi studies.52 53 Each panel will include 
a minimum of 15–20 participants. The requirement to 
complete all rounds of the study will be emphasised to 
limit attrition while adhering to ethical principles.52
Consensus meeting
Overview
A consensus meeting will be held with patients and 
healthcare professionals to finalise the COS. We will aim 
to gather approximately 20–25 participants with an equal 
representation from each stakeholder group. The objec-
tive of the consensus meeting is to discuss outcomes for 
which there was disagreement in round 3 of the Delphi 
study and to validate and agree on a final list of outcomes35 
which will constitute the COS.
The results from each round of the Delphi study will be 
presented and the consensus results from round 3 of the 
Delphi. It will then be proposed that any outcome cate-
gorised as ‘consensus IN’ across all stakeholder groups 
be included in the final COS, and any outcome catego-
rised as ‘consensus OUT’ across all stakeholder groups be 
excluded. Attendees will vote anonymously on electronic 
keypads to accept this proposal or to suggest outcomes 
from this group which necessitate further discussion.
All other outcomes including those categorised as 
‘consensus IN’ or ‘consensus OUT’ by one or two stake-
holder groups and those categorised as ‘NO consensus’ 
will then be discussed, and further rounds of voting will be 
used to agree the final COS. The purpose of the meeting 
is to ratify the final outcome set; therefore, the agenda of 
the meeting and processes used will be in part dependent 
on the consensus achieved through the Delphi study.
Consensus rules and voting
Consensus will be defined as being reached when less 
than 30% of voters disagree (ie, 70% agree or are unsure). 
Voting will be anonymous using electronic handsets and 
voting software, with real-time results fed back to the 
group once voting is closed. All meeting participants 
will be permitted to vote (observers, study management 
group and facilitators will be excluded from voting).
Recruitment
All participants who have completed the online Delphi 
will be able to register their interest in participation in 
the consensus meeting (tick box on Delphi registration 
page). A purposive sample of participants from all stake-
holder groups (patients, surgical and non-surgical health-
care professionals), who have registered their interest 
and completed all rounds of the Delphi, will be invited to 
attend the consensus meeting.
Patient and public involvement
Patient and public have been involved in the inception 
and design of the study. We received input from patients 
with TBPI on the design of all patient facing documents. 
box 1 Consensus criteria
Consensus IN (consensus that outcome should be included in the core 
of outcome set (COS))—70% or more participants scoring an outcome 
as critically important (7–9) and <15% or fewer participants rate the 
outcome as limited importance (1–3).
Consensus OUT (consensus that outcome should not be included in the 
COS)—70% or more participants scoring an outcome as limited im-
portance (1–3) and <15% of participants scoring an outcome as very 
important (7–9).
NO consensus (uncertainty about importance of outcome)—anything 
else.
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A user-led organisation (Trauma Brachial Plexus Injury 
Group UK) has acted as a collaborator. We have carefully 
assessed the burden of the project on study participants. 
We intend to disseminate the main results to study partic-
ipants and other patients with TBPI and will seek patient 
and public involvement in the development of an appro-
priate method of dissemination.
EtHICs And dIssEMInAtIon
All interview participants will provide informed written 
consent. Consent will be taken as implicit for Delphi 
participants, registering via the website and submitting 
completed questionnaires.
The protocol, we propose, observes COMET and 
COS-STAD recommendations35 36 and represents a robust 
method for COS development. There will be active partic-
ipation of patients, international healthcare professionals 
and academics in each phase. In addition, a patient and 
a clinical advisory group will oversee the project. This will 
ensure that outcomes important to all stakeholders are 
represented in the final COS.
Once the final COS is agreed, further work is planned 
to develop a core outcome measurement instrument 
set. This future work will aim to recommend a measure-
ment instrument for each outcome in the COS. The 
systematic review in this protocol will have identified 
existing measurement instruments. Guidance from COS 
for the selection of health Measurement INstruments54 
and Prinsen et al55 will be then followed to identify the 
measurement instruments with the highest validity, reli-
ability and responsiveness in the TBPI population.
Engaging a wide range of international participants in 
all stakeholder groups will facilitate dissemination and 
uptake of the COS in this area of healthcare in the future. 
The COS development has been registered on COMET, 
an international public database. Successful implementa-
tion of COS in other healthcare areas has resulted in a 
significant change in the quality and relevance of research 
and enhanced clinical practice globally.56 It is anticipated 
that a COS for TBPIs will do the same and improve clin-
ical decision making, patient care and outcomes in this 
area.
Acknowledgements The authors want to thank all patients and health 
professionals for their contribution to the study design and particularly the trauma 
brachial plexus charity group (UK) for their ongoing support.
Contributors CM wrote the paper and conceived the project with the support of 
CJ-H and DMP. JC contributed knowledge on qualitative research. DK contributed 
knowledge on core outcome set development. CJ-H, JC, DMP and DK edited and 
critically revised the paper. All authors have read and approved the manuscript. 
Funding The work is supported by the Health Education England and National 
Institute for Health Research Clinical Doctoral Research Fellowship CDRF 
ICA-CDRF-2017-03-039. 
disclaimer This article presents research funded by the National Institute for 
Health Research (NIHR). The views expressed are those of the authors and not 
necessarily those of the National Health Service, the NIHR or the Department of 
Health.
Competing interests DMK reports grants from Macmillan Cancer Support, 
Innovate UK, the National Institute for Health Research (NIHR), NIHR Birmingham 
Biomedical Research Centre and NIHR Surgical Reconstruction and Microbiology 
Research Centre at the University of Birmingham and University Hospitals 
Birmingham NHS Foundation Trust and personal fees from Merck outside the 
submitted work. DMP reports personal fees from Polyganics, personal fees from 
Axogen Inc and personal fees from Gecko-Biomedical outside the submitted work. 
Patient consent for publication Not required.
Ethics approval Ethical approval for the interviews, Delphi and consensus 
meeting was granted on 03/01/2019 by the West Midlands-Solihull Research Ethics 
Committee (Ref 18/WM/0297).
Provenance and peer review Not commissioned; peer reviewed for ethical and 
funding approval prior to submission.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
rEFErEnCEs
 1. Jain DK, Bhardwaj P, Venkataramani H, et al. An epidemiological 
study of traumatic brachial plexus injury patients treated at an Indian 
centre. Indian J Plast Surg 2012;45:498–503.
 2. Estrella EP. Functional outcome of nerve transfers for upper-
type brachial plexus injuries. J Plast Reconstr Aesthet Surg 
2011;64:1007–13.
 3. Ciaramitaro P, Mondelli M, Logullo F, et al. Traumatic peripheral nerve 
injuries: epidemiological findings, neuropathic pain and quality of life 
in 158 patients. J Peripher Nerv Syst 2010;15:120–7.
 4. Flores LP. [Epidemiological study of the traumatic brachial plexus 
injuries in adults]. Arq Neuropsiquiatr 2006;64:88–94.
 5. Midha R. Epidemiology of brachial plexus injuries in a multitrauma 
population. Neurosurgery 1997;40:1182–9. Discussion 1188-9.
 6. Kouyoumdjian JA. Peripheral nerve injuries: a retrospective survey of 
456 cases. Muscle Nerve 2006;34:785–8.
 7. Wellington B. Quality of life issues for patients following traumatic 
brachial plexus injury – Part 2 research project. Int J Orthop Trauma 
Nurs 2010;14:5–11.
 8. Brown H, Johnson K, Gilbert A, et al. The lived experience of 
motor recovery of elbow flexion following Oberlin nerve transfer: A 
qualitative analysis. Hand Ther 2018;23:130–8.
 9. Kehoe A, Smith JE, Edwards A, et al. The changing face of major 
trauma in the UK. Emerg Med J 2015;32:911–5.
 10. National Audit Office. Major Trauma Care in England. London, 2010.
 11. Lecky F, Coats T. Press Release on Major Trauma 2015. The Trauma 
Audit and Research Network. 2015 https://www. tarn. ac. uk/.
 12. Lecky F, Boumara O, Woodford M, et al. Epidemiology of 
Polytrauma. In: Pape H, Peitzman A, Schwab W, eds. Damage 
Control Management in the Polytrauma patient. New York: Springer, 
2010:13–24.
 13. Dutton RP, Stansbury LG, Leone S, et al. Trauma mortality in mature 
trauma systems: are we doing better? An analysis of trauma mortality 
patterns, 1997-2008. J Trauma 2010;69:620–6.
 14. Bhandari PS, Maurya S. Recent advances in the management of 
brachial plexus injuries. Indian J Plast Surg 2014;47:191–8.
 15. Dolan RT, Butler JS, Murphy SM, et al. Health-related quality of life 
and functional outcomes following nerve transfers for traumatic 
upper brachial plexus injuries. J Hand Surg Eur Vol 2012;37:642–51.
 16. Tung TH, Mackinnon SE. Nerve transfers: indications, techniques, 
and outcomes. J Hand Surg Am 2010;35:332–41.
 17. Leechavengvongs S, Witoonchart K, Uerpairojkit C, et al. Combined 
nerve transfers for C5 and C6 brachial plexus avulsion injury. J Hand 
Surg Am 2006;31:183–9.
 18. Teboul F, Kakkar R, Ameur N, et al. Transfer of fascicles from the 
ulnar nerve to the nerve to the biceps in the treatment of upper 
brachial plexus palsy. J Bone Joint Surg Am 2004;86:1485–90.
 19. Dy CJ, Garg R, Lee SK, et al. A systematic review of outcomes 
reporting for brachial plexus reconstruction. J Hand Surg Am 
2015;40:308–13.
 20. McDonald J, Pettigrew J. Traumatic brachial plexus injury: the lived 
experience. Br J Occup 2014; 77: 147- 54.
 21. Choi PD, Novak CB, Mackinnon SE, et al. Quality of life and 
functional outcome following brachial plexus injury. J Hand Surg Am 
1997;22:605–12.
 22. Franzblau LE, Shauver MJ, Chung KC, et al. Patient satisfaction 
and self-reported outcomes after complete brachial plexus avulsion 
injury. J Hand Surg Am 2014;39:948.
 o
n
 26 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030146 on 14 June 2019. Downloaded from 
7Miller C, et al. BMJ Open 2019;9:e030146. doi:10.1136/bmjopen-2019-030146
Open access
 23. Mancuso CA, Lee SK, Dy CJ, et al. Expectations and limitations due 
to brachial plexus injury: a qualitative study. Hand 2015;10:741–9.
 24. NHS Clinical Advisory Group. Regional Networks for Major Trauma. 
2010.
 25. Hill B, Williams G, Olver J, et al. Letter regarding outcome reporting 
for brachial plexus reconstruction. J Hand Surg Am 2015;40:1504.
 26. Morris M, Daluiski A, Dy C. A thematic analysis of online discussion 
boards for brachial plexus injury. J Hand Surg;  2016; 41:813-8.
 27. Williamson PR, Altman DG, Blazeby JM, et al. Developing core 
outcome sets for clinical trials: issues to consider. Trials 2012;13:132.
 28. Williamson P, Altman D, Blazeby J, et al. Driving up the quality and 
relevance of research through the use of agreed core outcomes. J 
Health Serv Res Policy 2012;17:1–2.
 29. Gargon E, Gurung B, Medley N, et al. Choosing important health 
outcomes for comparative effectiveness research: a systematic 
review. PLoS One 2014;9:e99111.
 30. Kirkham JJ, Gargon E, Clarke M, et al. Can a core outcome set 
improve the quality of systematic reviews?-a survey of the Co-
ordinating Editors of Cochrane Review Groups. Trials 2013;14:21.
 31. Tugwell P, Boers M, Brooks P, et al. OMERACT: an international 
initiative to improve outcome measurement in rheumatology. Trials 
2007;8:38.
 32. Williamson PR, Altman DG, Blazeby JM, et al. The COMET 
(Core Outcome Measures in Effectiveness Trials) Initiative. Trials 
2011;12:A70.
 33. Harman NL, Bruce IA, Kirkham JJ, et al. The importance of 
integration of stakeholder views in core outcome set development: 
Otitis Media with Effusion in Children with Cleft Palate. PLoS One 
2015;10:e0129514.
 34. Page MJ, McKenzie JE, Kirkham J, et al. Bias due to selective 
inclusion and reporting of outcomes and analyses in systematic 
reviews of randomised trials of healthcare interventions. Cochrane 
database Syst Rev 2014;10:MR000035.
 35. Williamson PR, Altman DG, Bagley H, et al. The COMET Handbook: 
version 1.0. Trials 2017;18:280.
 36. Kirkham JJ, Davis K, Altman DG, et al. Core Outcome Set-STAndards 
for Development: The COS-STAD recommendations. PLOS Med 
2017;14:e1002447.
 37. Macefield RC, Jacobs M, Korfage IJ, et al. Developing core 
outcomes sets: methods for identifying and including patient-
reported outcomes (PROs). Trials 2014;15:49.
 38. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting 
qualitative research (COREQ): a 32-item checklist for interviews and 
focus groups. Int J Qual Heal Care 2007;19:349–57.
 39. Ritchie J, Lewis J. Qualitative research practice A Guide for 
Social Science Students and Researchers. 2 edn. London: SAGE 
publications Inc, 2013.
 40. Coyne IT. Sampling in qualitative research. Purposeful and theoretical 
sampling; merging or clear boundaries? J Adv Nurs 1997;26:623–30.
 41. Patton MQ. Qualitative research and evaluation methods : integrating 
theory and practice 4th edn. London: SAGE publications Inc 2015.
 42. Guest G, Bunce A, Johnson L. How Many Interviews Are Enough? 
Field methods 2006;18:59–82.
 43. Elo S, Kyngäs H. The qualitative content analysis process. J Adv 
Nurs 2008;62:107–15.
 44. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res 
Psychol 2006;3:77–101.
 45. Dodd S, Clarke M, Becker L, et al. A taxonomy has been developed 
for outcomes in medical research to help improve knowledge 
discovery. J Clin Epidemiol 2018;96:84–92.
 46. Schmitt J, Apfelbacher C, Spuls PI, et al. The Harmonizing Outcome 
Measures for Eczema (HOME) Roadmap: A Methodological 
Framework to Develop Core Sets of Outcome Measurements in 
Dermatology. J Invest Dermatol 2015;135:24–30.
 47. Chiarotto A, Deyo RA, Terwee CB, et al. Core outcome domains 
for clinical trials in non-specific low back pain. Eur Spine J 
2015;24:1127–42.
 48. Harman NL, Wilding J, Curry D, et al. Selecting Core Outcomes for 
Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): 
study protocol for the development of a core outcome set Trials 
2018; 19:427.
 49. Keeley T, Khan H, Pinfold V, et al. Core outcome sets for use in 
effectiveness trials involving people with bipolar and schizophrenia 
in a community-based setting (PARTNERS2): study protocol for the 
development of two core outcome sets. Trials 2015;16:47.
 50. Murphy MK, Black NA, Lamping DL, et al. Consensus development 
methods, and their use in clinical guideline development. Health 
Technol Assess 1998;2:1–88.
 51. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing 
the question and deciding on important outcomes. J Clin Epidemiol 
2011;64:395–400.
 52. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique 
to determine which outcomes to measure in clinical trials: 
recommendations for the future based on a systematic review of 
existing studies. PLoS Med 2011;8:e1000393.
 53. Allin BSR, Hall NJ, Ross AR, et al. Development of a 
gastroschisis core outcome set. Arch Dis Child Fetal Neonatal Ed 
2019; 104:F76-F82.
 54. Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist 
for assessing the methodological quality of studies on measurement 
properties of health status measurement instruments: an 
international Delphi study. Qual Life Res 2010;19:539–49.
 55. Prinsen CAC, Vohra S, Rose MR, et al. . Trials 2016;17: How to select 
outcome measurement instruments for outcomes included in a " 
Core Outcome Set " – a practical guideline.
 56. Kirkham JJ, Boers M, Tugwell P, et al. Outcome measures in 
rheumatoid arthritis randomised trials over the last 50 years. Trials 
2013;14:324.
 o
n
 26 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030146 on 14 June 2019. Downloaded from 
